Omeros buying Nura, considering IPO

09/8/2006 |

Seattle-based Omeros Corp. is buying Nura in a deal that includes three venture capital groups -- some of the original investors in Nura -- making a "substantial investment" in Omeros. The merger will combine Nura's treatments for Parkinson's disease, schizophrenia and sleep disorders with Omeros' drug to reduce pain following arthroscopic surgery. Omeros is considering going public in 2007.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL